This two-page table is derived from recommendations in the 2006 update of the American Society of Clinical Oncology'sĀ guideline for the use of antiemetics in oncology. It provides detailed drug, dose, and schedule recommendations for antiemetic regimens based on the level of emetic risk and whether emesis was chemotherapy induced or radiation induced. Recommendations are also provided for the following situations:
American Society of Clinical Oncology
Disease/Condition-Related; Guideline-Related
Last updated: April 11, 2008.
AHRQ Home | Questions? | Contact AHRQ | Site Map | Accessibility | Privacy Policy | Freedom of Information Act | Disclaimers U.S. Department of Health & Human Services | The White House | USA.gov: The U.S. Government's Official Web Portal
Agency for Healthcare Research and Quality 540 Gaither Road Rockville, MD 20850 Telephone: (301) 427-1364